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Mild cognitive impairment (MCI), a well-defined non-motor manifestation of Parkinson’s 
disease (PD), greatly impairs functioning and quality of life. However, the contribution of 
cerebral perfusion, quantified by arterial spin labelling (ASL), to MCI in PD remains poorly 
understood. The selection of an optimal delay time is difficult for single-delay ASL, a 
problem which is avoided by multi-delay ASL. This study uses a multi-delay 
multi-parametric ASL to investigate cerebral perfusion including cerebral blood flow (CBF) 
and arterial transit time (ATT) in early-stage PD patients exhibiting MCI using a voxel-based 
brain analysis. MRI data were acquired on a 3.0 T system at rest in 39 early-stage PD patients 
either with MCI (PD-MCI, N=22) or with normal cognition (PD-N, N=17), and 36 age- and 
gender-matched healthy controls (HC). CBF and ATT were compared among the three groups 
with SPM using analysis of variance followed by post hoc analyses to define regional 
differences and examine their relationship to clinical data. PD-MCI showed prolonged ATT in 
right thalamus compared to both PD-N and HC, and in right supramarginal gyrus compared 
to HC. PD-N showed shorter ATT in left superior frontal cortex compared to HC. Prolonged 
ATT in right thalamus was negatively correlated with the category fluency test (p = 0.027, r = 
-0.495) in the PD-MCI group. This study shows that ATT may be a more sensitive marker 
than CBF for the MCI, and highlights the potential role of thalamus and inferior parietal 
region for MCI in early stage PD. 
Keywords: Parkinson’s disease; mild cognitive impairment; arterial spin labeling; 
multi-delay; arterial transit time; cerebral blood flow. 
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Parkinson's disease (PD) is a progressive neurodegenerative disease (Jankovic, 2008). 
Mild cognitive impairment (MCI) is a well-defined non-motor manifestation of PD, which 
greatly impairs functioning and quality of life and frequently progresses to dementia 
(Svenningsson et al., 2012). PD patients exhibiting MCI (PD-MCI) are candidates for 
disease-modifying intervention before irreversible changes occur, and this has prompted the 
search for objective imaging biomarkers to predict cognitive decline and monitor disease 
progression. 
Arterial spin labeling (ASL) is a magnetic resonance imaging (MRI) method for 
quantifying cerebral blood flow (CBF) and arterial transit time (ATT) by using magnetically 
labeled arterial blood water as an endogenous tracer. Because it is entirely non-invasive, and 
needs no radioactive tracer or other contrast agent (Detre et al., 1992), ASL has been 
increasingly used to investigate perfusion in healthy controls (HC) and several neurological 
and psychiatric disorders (Hales et al., 2014; Lin et al., 2016; Lui et al., 2009), including PD 
(Al-Bachari et al., 2014; Al-Bachari et al., 2017; Fernandez-Seara et al., 2012; Lin et al., 
2016; Melzer et al., 2011; Wei et al., 2016).  
ASL studies in PD have generally employed a single post-labeling delay (PLD) time for 
estimating CBF (Fernandez-Seara et al., 2012; Lin et al., 2016; Melzer et al., 2011). The main 
limitation of single-delay ASL is that the delay time between labelling in the feeding arteries 
and arrival of labeled blood in tissue (i.e. the ATT) can have a large effect on the perfusion 
signals (Wang et al., 2014), and a long ATT, larger than the PLD, could result in 
underestimation of brain perfusion. The selection of a single optimal delay time is difficult 




because ATT varies widely among patients with different vascular and perfusion 
characteristics (Johnston et al., 2015). Acquisition of serial ASL images at multiple PLDs 
offers potential advantages over single PLD ASL, allowing calculation of multiple 
hemodynamic parameters (ATT and CBF) and improving accuracy of CBF quantification 
(Wang et al., 2013). Furthermore, by combining single-shot 3D gradient and spin echo 
(GRASE), background suppression and pseudo-continuous ASL (pCASL), the temporal 
stability of ASL image series has been improved within a clinically reasonable total scan time 
(Gunther et al., 2005). ATT and CBF alterations have previously been reported in ASL studies 
of PD clinical phenotypes (Al-Bachari et al., 2017). However, little is known about how such 
changes might be associated with MCI. 
Another limitation of previous studies in PD is that the patients have usually represented 
a broad disease spectrum of disease severity, collected in a single ‘non-dementia’ group 
(Syrimi et al., 2017). By contrast the separation of non-demented PD patients into PD-MCI 
and PD with normal cognition (PD-N) promises greater discrimination in identifying 
underlying brain changes prior to PD with dementia (PD-D) (Melzer et al., 2012), avoiding 
this potential confounding effect.  
  Thus, the aim of this study was to apply a multi-delay multi-parametric pCASL protocol 
with background-suppressed 3D GRASE readout to study cerebral perfusion using 
voxel-based whole brain analysis in early-stage PD-MCI patients, and investigate possible 
relationships with clinical variables. 
 
 




MATERIALS AND METHODS 
Participants 
  A total of 39 right-handed PD patients were recruited from the movement disorders 
outpatient clinic of West China Hospital of Sichuan University. All met UK Parkinson’s 
Disease Society’s criteria. Twenty-two PD-MCI patients and 17 PD-N patients were 
diagnosed in accordance with the new Movement Disorder Society (MDS) Task Force 
criteria, Level II (Litvan et al., 2012). At the initial visit all patients were either drug-naïve or 
in an ‘off’ state defined as at least 12 hours after the last dose of dopaminergic medication; 
they received a comprehensive assessment (Helmich et al., 2010), including neurological 
examination, neuropsychological testing, and MRI scan. Clinical assessments were 
performed by an experienced neurologist blinded to the MRI results. The Unified PD Rating 
Scale (UPDRS) part III was used to assess motor disability (Goetz et al., 2008), and Hoehn 
and Yahr stage (H&Y stage) to evaluate disease severity (Hoehn and Yahr, 2001). Exclusion 
criteria at recruitment included atypical Parkinsonian disorder, prior learning disability, and 
history of other neurologic conditions including moderate or severe head injury, stroke, 
vascular dementia, major psychiatric or medical illness.  
  Thirty-six HC with no history of neurologic and psychiatric disease were recruited from 
the local area by poster advertisements. HC underwent a multidimensional assessment, 
including neurological and global cognitive evaluation, and were included in the study only if 
all items were normal. 
  This study was approved by the Research Ethics Committee of the West China Hospital of 
Sichuan University. Written informed consent was obtained from all participants before 




enrollment in the study.  
Neuropsychological assessment 
  Cognitive performance was evaluated by trained neurologists using a standardized 
neuropsychological battery. Global cognition was evaluated using the Mini Mental State 
Examination (MMSE) (Folstein et al., 1975) and Montreal Cognitive Assessment (MoCA) 
(Dalrymple-Alford et al., 2010). As recommended by the MDS Task Force 2012, specific 
cognitive domains including attention and working memory, executive function, language, 
memory, and visuospatial function were assessed (Litvan et al., 2012). Attention and working 
memory was assessed using the Trail Making Test Part A (TMT-A) and the digit span 
backward task; executive function was evaluated with category fluency test and 10 points 
Clock Drawing Test (CLOX-1); language was evaluated with WAIS-IV Similarities and 
Boston Naming Test (BNT); memory was evaluated with Hopkins Verbal Learning Test 
(HVLT) and Brief Visuospatial Memory Test–Revised (BVMT-R); visuospatial function was 
evaluated with Benton’s Judgment of Line Orientation (JLO) and Clock Copying (CLOX-2). 
  To assess concordance with MDS level 2 criteria for PD-MCI, performance on the 
suggested five cognitive domains (attention/working memory, executive function, language, 
memory, and visuospatial function) was analyzed, and impairment was defined as test 
performance 1.5 standard deviation (SD) below appropriate norms. Categorization as 
PD-MCI required impairment on at least two neuropsychological tests, represented by either 
two impaired tests in one cognitive domain or one impaired test in two different cognitive 
domains. PD patients who did not fulfill criteria for PD-MCI or PD-D were classified as 
PD-N.  





  The MRI data were acquired on a 3T Siemens Tim Trio system with a 12-channel 
phased-array head coil. Participants were fitted with soft ear plugs, positioned comfortably in 
the coil and instructed to relax and keep still. Head motion was minimized using foam pads. 
ASL scans were performed using a 4-delay pCASL protocol with background-suppressed 
single-shot 3D GRASE readout. Imaging parameters were as follows: 4 PLD times 
1400/1800/2200/2600 ms; labelling pulse duration 1500 ms; repetition time (TR) 
3500/3500/3500/3500 ms; echo time (TE) 22 ms; echo-train length 15; voxel size 
3.44×3.44×5.00 mm3; 26 slices covering the whole brain; 12 pairs of tag/control images for 
each delay with a total scan time of 5.9 min. An M0 image was acquired using TR = 5000 ms 
and PLD = 4000 ms (scan time = 15 s). 
Image Processing 
  Images were processed using a self-compiled MATLAB program called ASLFit (provided 
by Siemens Healthcare, MR Collaborations NE Asia) based on SPM8 (Welcome Trust Centre 
for Neuroimaging, UCK, UK) and MATLAB 2010a (Mathworks, Natick, MA). First, motion 
correction was performed for all control and label images of the same series using the M0 
image as a reference. After motion correction, mean perfusion difference images ΔM(i) were 
generated for each PLD by subtracting the label and control images, followed by averaging. 
The weighted delay (WD) was calculated using the images ΔM(i) by equation (1):  
          4 1i4 1i iMiMΔiWWD                                     (1)        
and converted to ATT based on the theoretical relationship between the WD and ATT (Dai et 
al., 2012; Wang et al., 2013). The CBF at each delay was calculated using the equation (2): 











        (2) 
where λ (= 0.9 g/ml) is the blood/tissue water partition coefficient, R (= 0.61 s−1) is the 
longitudinal relaxation rate of blood at 3T, α (= 0.8) is the tagging efficiency, M0 is the 
equilibrium magnetization of brain tissue, w(i) is the PLD (= 1400/1800/2200/2600 ms), and 
τ ( = 1500 ms) is the duration of the labelling pulse. The final CBF was taken as the mean of 
the estimated CBF at each PLD. All of the ASL images were spatially normalized to the 
Montreal Neurological Institute (MNI) template space with 79×95×68 dimension using 
SPM8, and smoothed using a 6 mm full width at half-maximum (FWHM) Gaussian kernel. 
Voxel-based brain mapping analysis 
  Whole-brain voxel-wise analysis of ATT and CBF tested the main effect of diagnosis 
(PD-MCI, PD-N and HC) using ANOVA in SPM8 with the age, gender, years of education 
and LEDD as covariates. The global ATT and CBF were not different among groups (p > 
0.05 in ANOVA), and were therefore not included as covariates in the analysis. Post hoc 
evaluations of significant ANOVA findings in these regions were then performed with 
secondary two-tailed independent sample t-tests. Values for the regions showing significant 
differences among three groups were extracted using the Mars Bar toolbox (http://marsbar. 
sourceforge.net).  
  The comparison of ATT, CBF at 1400 ms, 1800 ms, 2200 ms and 2600 ms, and mean CBF 
between all PD patients and HC was performed using two-sample t tests. Statistical maps 
were overlaid onto a high-resolution brain template in the standard MNI space using 
MRIcron software (http://www.mccauslandcenter.sc.edu/crnl/mricron/index.html). 
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  The voxel-wise ANOVA and t tests were performed with the threshold set at p ˂ 0.001 
corrected using AlphaSim (http://afni.nimh.nih.gov/afni/doc/manual/ AlphaSim) taking a 
contiguous cluster of at least 48 voxels as significant. To correct for multiple comparisons, a 
cluster analysis was conducted using a Monte Carlo simulation applied with the Resting-State 
fMRI Data Analysis Toolkit (REST) (Song et al., 2011) of the AlphaSim program, smoothed 
with a 6-mm Gaussian kernel with 1000 iterations. The vertex-wide threshold was set at p ˂ 
0.001 for simulation and clustering, and the results where cluster size ≥ 48 were considered 
significant if they survived a clusterwise probability of p ˂ 0.05.    
  We conducted partial correlation analyses between the average regional values in these 
affected regions with cognitive scores with age, gender, years of education and Levodopa 
equivalent daily dose (LEDD) as covariates. In addition, voxel-wise regression analyses were 
performed to evaluate the relationship between ATT and CBF and five cognitive domain z 
scores in PD, with age, gender, years of education and UPDRS III as covariates. Raw scores 
for cognitive tests were transformed to z scores on the basis of normative data from HC at our 
center. Cognitive domain scores were calculated by averaging z scores for 
neuropsychological tests within each of the specific domains. Separate regression models 
were performed for each cognitive domain. All regression results were corrected for multiple 
comparisons using family wise error (FWE corrected, p<0.001). 
Statistical analysis 
  Quantitative variables were compared across groups using the independent-sample t test 
and Kruskal–Wallis test or ANOVA (followed by Tukey post-hoc pairwise comparisons if 
significant). Qualitative variables were compared using a chi-squared test. The threshold for 




these analyses was set at p < 0.05. Statistical analysis of the demographic and clinical data 
was performed in SPSS 16.0 software (http://www.spss.com). 
   
RESULTS 
Demographic and Clinical Comparisons 
  The demographic and clinical data are summarized in Table 1. Age, gender, years of 
education and MMSE did not differ significantly among the three groups. PD-MCI and PD-N 
were similar in age at onset, disease duration, H&Y stage, LEDD, and UPDRS III scores. 
PD-MCI had lower global cognition (MoCA: 19.1 vs 24.3, p < 0.001) scores compared with 
PD-N. PD-MCI demonstrated significantly poorer performance on executive function, 
memory and language abilities. 
Three-group and between-group comparisons 
  There were no significant differences in CBF among the three groups. 
  The three groups had significant differences of ATT in right supramarginal gyrus (SMG), 
right thalamus, and left superior frontal gyrus (SFG) (Figure 1, Table 2). Post-hoc t tests 
showed the following: PD-MCI compared to HC showed prolonged ATT in right SMG and 
right thalamus; PD-N compared to HC showed shorter ATT in left SFG; PD-MCI compared 
to PD-N showed prolonged ATT in right thalamus (p < 0.001). Figure 2 illustrates the 
changes in the ATT values in these affected regions. Comparisons between all pairs of groups 
using unpaired t-tests are shown in Tables S1-S3. 
All PD patients and HC comparison 
  All PD patients showed prolonged ATT in right SMG, right precuneus and bilateral middle 




occipital gyrus (MOG) (p < 0.001) (Table 3, Figure 3). The CBF at 1800 ms in right caudate 
and the CBF at 2200 ms in right orbitofrontal cortex were decreased (p < 0.001) (Table 3, 
Figure 4). 
Correlation analysis 
  In PD-MCI, prolonged ATT in right thalamus (MNI coordinates: x = 8, y = −26, z = 2) was 
negatively correlated with the category fluency test of executive function (p = 0.027, r = 
-0.495) (Figure 5). There were no significant correlations between other neuropsychological 
assessments and prolonged ATT in right thalamus and right SMG. In PD-N, there were no 
significant correlations between ATT and neuropsychological assessment. As all patients had 
a diagnosis of PD, with MCI determined by the cognitive assessment, the two patients groups 
were pooled in an exploratory analysis using nominal significance thresholds to examine 
associations of ASL findings with neuropsychological tests. Only the negative correlation 
between category fluency test and ATT in right thalamus was significant (p = 0.039, r = 
-0.521). 
  Results from voxel-wise multiple regression to evaluate the relationship between mean 
CBF and cognitive domain scores in PD are reported in Table 4 and Figure S1. The mean 
CBF in left middle frontal gyrus (MFG) were positively correlated with the executive (r = 
0.359, p = 0.034) and visuospatial function z scores (r = 0.339, p = 0.046). No significant 
association was identified between mean CBF and any other cognitive domain score, nor 
were CBF at 1400ms, 1800ms, 2200ms, 2600ms or ATT significantly correlated with the 
cognitive domain scores.    
 





  In this study we investigated cerebral perfusion alterations in early stage PD-MCI patients 
using multi-delay multi-parametric pCASL. ATT was more sensitive than CBF in detecting 
altered cerebral perfusion in PD-MCI patients. The most prominent abnormality in PD-MCI 
was a significant prolongation of ATT in right thalamus and right SMG compared to PD-N 
and HC. This prolonged right thalamus ATT in PD-MCI was negatively correlated with 
executive function. In addition, PD-N showed shorter ATT in prefrontal cortex relative to HC. 
By contrast we found no differences in CBF among the three groups. Comparing all PD 
patients with HC, there was prolonged ATT in right SMG, right precuneus and bilateral MOG, 
as well as decreased CBF at 1800 ms PLD in right caudate and at 2200 ms PLD in right 
orbitofrontal cortex. 
  What do these findings mean in physiological terms? ATT represents the time taken for the 
magnetically labeled blood to flow from the labeling region to the vascular compartment of 
the imaging sections (Wang et al., 2003; Yoshiura et al., 2009b). Prolonged ATT in PD 
patients compared to controls has been previously reported (Al-Bachari et al., 2014; 
Al-Bachari et al., 2017). Pathological studies of PD have shown endothelial degeneration 
with preservation of basement membrane leading to increased string vessel formation (Yang 
et al., 2015), which may suggest a possible pathological relevance for this prolonged ATT. 
Prolonged ATT in some non-PD studies has been postulated to reflect age-driven structural 
cerebrovascular changes, e.g. increased vessel tortuosity, increased rarefaction and arteriolar 
wall damage (Liu et al., 2012), inflammation or chronic vasodilation of the resistance vessels 
in multiple sclerosis (Paling et al., 2014), or recruitment of collateral pathways in acute 




ischemia (MacIntosh et al., 2010). In short, prolongation of ATT might be attributed to any 
factor which increases path length or decreases flow velocity. 
  The prolonged ATT of right thalamus was found in PD-MCI compared to PD-N and HC, 
and correlates with the executive cognitive domain. Grey matter atrophy and cortical thinning 
in the thalamus have been reported in PD-MCI (Chen et al., 2016; Danti et al., 2015). 
Previous ASL studies found decreased thalamic CBF in PD patients including PD-D with 
relatively advanced disease (Lin et al., 2016; Melzer et al., 2011). The current study shows 
that a thalamic hemodynamic abnormality also occurs in PD-MCI with early-stage disease. 
Besides sensory and motor functions (Herrero et al., 2002), the thalamus plays an important 
role in cognitive function, and lesions may lead to abnormalities of multiple cognitive 
domains, covering attention, executive function, language, memory, and visuospatial function 
(De Witte et al., 2008; Radanovic et al., 2003; Van der Werf et al., 2003). Here, the executive 
function reflected by the category fluency test was negatively correlated with ATT in the 
thalamus, in line with recent research showing that the thalamic local shape volume in 
PD-MCI is associated with semantic fluency tests (Chung et al., 2017). Poor performance in 
semantic fluency tests has been associated with a higher risk of developing dementia 
(Williams-Gray et al., 2009). A recent SPECT study found that cognitive functions in PD 
patients were positively correlated with CBF in the thalamus (Wakamori et al., 2014). The 
present ASL data strengthens the evidence for the hemodynamics of the thalamus as a 
potential biomarker for the development of cognitive impairment in PD. 
  Furthermore, we also identified a prolonged ATT in the right SMG of PD-MCI compared 
to HC. SMG has been shown to be involved in a wide range of cognitive tasks including 




spatial perception, mental imagery, action observation, visual-motor control, or motor skills 
cognitive control (Nickel and Seitz, 2005). The SMG is also part of the inferior parietal lobe, 
the core brain region of the default mode network, which is highly relevant for cognitive 
processes (Raichle et al., 2001). Previous structural and functional studies found cortical 
thinning and reduced functional connectivity in the inferior parietal lobe in PD-MCI (Hou et 
al., 2016; Pereira et al., 2014). Our results align with the pattern of posterior hypoperfusion 
and hypometabolism characterized by prolonged ATT and decreased CBF in PD, PD-MCI 
and PD-D previously detected by ASL, SPECT and PET studies (Al-Bachari et al., 2014; 
Al-Bachari et al., 2017; Eckert et al., 2007; Lin et al., 2016; Melzer et al., 2011; Nobili et al., 
2009; Pappata et al., 2011; Syrimi et al., 2017), which can be assumed to contribute to 
impaired cognition. ASL-derived functional connectivity analyses with seeds in thalamus 
have revealed increased connectivity in SMG in PD patients (Fernandez-Seara et al., 2015). 
Together with the present results, this all suggests that early involvement of subcortical 
(thalamus) and posterior cortical regions (SMG) could be early markers of cognitive deficit in 
PD patients. The utility of this pattern in predicting prodromal dementia needs to be 
evaluated in longitudinal studies.  
  By contrast, compared with HC, PD-N showed shorter ATT in the left SFG. There are 
reports of reduced gray matter density and cortical thickness in frontal lobe in PD-N 
compared to HC (Chen et al., 2016; Hanganu et al., 2013; Nishio et al., 2010), but other 
studies have found no evidence of anatomical, functional or metabolic brain abnormalities in 
PD-N (Amboni et al., 2015; Lyoo et al., 2010; Weintraub et al., 2011). This apparent 
discrepancy may be due to differences in definitions of MCI, disease severity, image analysis 




techniques, sample sizes and neuropsychological tests, and merits further study. Although 
medication was withdrawn in treated PD at least 12 hours prior to MRI scanning, we cannot 
completely rule out the potentially confounding effects of chronic dopaminergic drugs, which 
may also have obscured alterations in the frontal cortex, as L-DOPA has been shown to 
modulate perfusion in this region (Lin et al., 2016). Additionally, involvement of the 
prefrontal cortex contributes to distinct motor manifestations, such as in PD patients with 
tremor (Picco et al., 2015). The decreased ATT we found in the PD-N group compared with 
HC may represent a compensatory response to the hypodopaminergic state. This would be 
consistent with studies showing enhanced prefrontal activity in cognitively intact PD at rest 
and during tasks (Picco et al., 2015; Zheng et al., 2014). On combining the two patients 
groups, we found the CBF in left MFG was positively correlated with z scores of executive 
and visuospatial function: the lower the z scores, indicating greater cognitive impairment, the 
lower CBF in the left MFG. In PD, executive function is positively correlated with 18F-DOPA 
uptake and FA in the frontal regions (Picco et al., 2015; Zheng et al., 2014), and the 
visuospatial impairment is associated with frontal gray matter reductions (Pereira et al., 2009). 
In combination with our present observations, this suggests that frontal areas may also play 
an important role in the cognitive impairments of PD. 
  We found no differences in CBF between the three groups. A similar lack of statistically 
significant differences in CBF between 14 PD patients and 14 controls has been also reported 
(Al-Bachari et al., 2014). The small sample size may potentially account for differences not 
reaching statistical significance. Small regions of lower CBF were found in 51 PD patients by 
comparison with 34 controls (Al-Bachari et al., 2017). When comparing all PD patients with 




HC we found decreased CBF in right caudate and right orbitofrontal cortex. This is in 
agreement with the parallel circuits linking the basal ganglia and cortex (Alexander et al., 
1986). This parallel loop model of striatal organization is broadly supported by studies of 
striatal anatomical and functional connections, hypoperfusion and hypometabolism using 
ASL and PET (Fernandez-Seara et al., 2012; Lehericy et al., 2004; Pappata et al., 2011; 
Postuma and Dagher, 2006; Wang et al., 2017; Wei et al., 2016). In addition, we found 
prolonged ATT in right precuneus and bilateral MOG in PD patients, in keeping with studies 
showing a similar pattern of posterior cortical hypoperfusion in PD patients compared to HC 
(Al-Bachari et al., 2017; Barzgari et al., 2018; Fernandez-Seara et al., 2012; Melzer et al., 
2011; Syrimi et al., 2017). Hypoperfusion in neurodegenerative states has been attributed to 
direct tissue loss or the result of loss of functional connectivity (Borghammer et al., 2010; 
Yoshiura et al., 2009a). Although the mechanism of occipital hypoperfusion in PD is unclear, 
it may be related to loss of dopaminergic neurons in the retina (Kamagata et al., 2011). ATT 
parameters have been shown to be more sensitive than CBF for characterizing stroke 
(MacIntosh et al., 2010) and neurovascular status in PD (Al-Bachari et al., 2014). The current 
study shows that ATT parameters may be more sensitive than CBF for characterizing PD with 
cognitive impairment. The lack of any significantly prolonged ATT in right thalamus when 
comparing PD with HC further suggests that alteration of ATT may be more likely to be 
related to MCI rather than to PD disease as such. 
 
  This study has a number of limitations. First, the relatively small sample size and unequal 
group size may have limited the detection of group differences. Our results need to be 




confirmed in future studies with large sample size of PD patients with MCI. Second, although 
the medications were withdrawn in some patients during MRI scanning, we still cannot 
completely eliminate the potentially confounding effects of chronic dopaminergic drugs. 
Third, in this cross-sectional study we are unable to observe the time course of brain changes 
associated with cognitive function decline. Fourth, unexpectedly, the 4-delay pCASL CBF 
showed no significant between-group difference compared to CBF acquired at the PLD of 
1800 ms and 2200 ms. Previous studies found that mean CBF showed slight improvement 
compared to the CBF at a single PLD in patients with stroke (Wang et al., 2013). A factor that 
might contribute to these discrepancies is that the estimated CBF reported in the current study 
is the mean of CBF at 4 PLDs; it did not take into account that different CBF at each PLD 
need to be fitted, which might weaken the differences observed at each PLD. Fifth, we used 4 
PLD time-points for the ASL acquisition, which was necessary in order to cover the cerebrum 
with vascular crushing gradients enabled (Al-Bachari et al., 2014). More time points may 
have increased the precision of the ATT measurements. 
CONCLUSION 
  This study revealed alterations of regional cerebral perfusion in the brains of PD patients 
with MCI using multi-delay multi-parametric ASL perfusion MRI to estimate the parameters 
of ATT and CBF. We have identified a cerebral functional abnormality in thalamus and 
inferior parietal cortex in early-stage PD-MCI patients, which may be a potential biomarker 
for the cognitive impairment; in particular ATT may be a more sensitive marker of changes in 
cerebral perfusion in PD-MCI than CBF. ASL perfusion MRI is completely noninvasive 
compared to nuclear imaging techniques and can safely be used for repeated assessments. 
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Figure 1. Arterial transit time (ATT) differences among PD-MCI, PD-N and HC. PD-MCI 
showed prolonged ATT in right thalamus compared to both PD-N and HC, and right 
supramarginal gyrus compared to HC. PD-N showed shorter ATT in left superior frontal 
cortex compared to HC. Statistical inferences were made with a voxel-level statistical 
threshold of p < 0.05 (corrected). Abbreviations: PD, Parkinson’s disease; PD-MCI, PD with 
mild cognitive impairment; PD-N, PD with normal cognition; HC, healthy controls; L, left; R, 
right; SFG, superior frontal gyrus; SMG, supramarginal gyrus. 
 
Figure 2. Arterial transit time (ATT) differences among PD-MCI, PD-N and HC compared 
by post-hoc contrasts within ANOVA. PD-MCI showed prolonged ATT in right thalamus 
compared to both PD-N and HC, and right supramarginal gyrus compared to HC. PD-N 
showed shorter ATT in left superior frontal cortex compared to HC. Abbreviations: PD, 
Parkinson’s disease; PD-MCI, PD with mild cognitive impairment; PD-N, PD with normal 
cognition; HC, healthy controls; L, left; R, right; SFG, superior frontal gyrus; SMG, 
supramarginal gurus; THA, thalamus. * P ˂ 0.05. 
 
Figure 3. Arterial transit time (ATT) differences between all PD patients relative to HC using 
two-sample t tests. PD patients showed prolonged ATT in right SMG, right precuneus and 
bilateral MOG. Abbreviations: PD, Parkinson’s disease; HC, healthy controls; L, left; R, right; 
SMG, supramarginal gyrus; MOG, middle occipital gyrus. 
 




Figure 4. Cerebral blood flow (CBF) differences between all PD patients relative to HC 
using two-sample t tests. The CBF at 1800 ms in right caudate and the CBF at 2200 ms in 
right OFC were decreased. Abbreviations: PD, Parkinson’s disease; HC, healthy controls; L, 
left; R, right; OFC, orbitofrontal cortex. 
 
Figure 5. Correlation between arterial transit time (ATT) and cognitive functions in the 
PD-MCI group. Prolonged ATT in right thalamus (MNI coordinates: x=8, y=−26, z=2) was 
negatively correlated with category influence test. Abbreviations: PD, Parkinson’s disease; 
PD-MCI, PD with mild cognitive impairment.  
